NCI-H508 In Vitro Protein Expression Analysis Assay (Immunoassays)

CAT#: ITS-1122-YF617
Target Cell Organism: Human
Target Cell Alternative Name: H508
Target Cell Name: NCI-H508
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide NCI-H508-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H508
Target Cell Organism
Human
Target Cell Background
NCI-H508 [H508] is a cell line derived from metastasis to the abdominal wall obtained from a patient after treatment with 5-fluorouracil. NCI-H508 [H508] is from the cecum of a White, 55-year-old, male patient with colorectal adenocarcinoma. This cell line was deposited by AF Gazdar.
Target Cell Alternative Name
H508
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoassays)
Short Description
NCI-H508-cell based In Vitro Protein Expression Analysis Assay (Immunoassays)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry